Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies
NCT ID: NCT05314478
Last Updated: 2024-11-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2022-03-24
2023-08-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
During the CLE test it is important that the part of the camera that remains outside the body is held securely in position near the forehead so that a clear and stable image is obtained using a headgear to secure the camera to the patient's head.
There are no headgears available on the market, so we have designed and manufactured one called HALOS (Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies).
This study is to ensure that HALOS is suitable for use, and to check we have understood and minimised the risks associated with the headgear. The headgear can then be used routinely within the Trust, improving the care that offered to patients.
We will recruit 30 male or female participants who need to undergo a CLE test. The study will be conducted at Broadgreen Hospital, Liverpool, UK. Before the CLE test, participants will attend a screening appointment to discuss the procedure. There will be no follow-up appointments.
During the CLE test, the participants will wear the HALOS headgear while exercising, and the clinician will monitor the image from the camera for signs of EILO. After the test, participants will be asked how tolerable the headgear was, and if they have any concerns about any aspect of it. The clinician will also record how clear and stable the camera image was, how easy it was to use, and any concerns about any aspect of it.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HelpILO - RCT on EILO Treatment
NCT04620343
Feasibility of Constant Work Rate Testing to Detect Exercise-induced Laryngeal Obstruction
NCT05558020
Is Laryngeal Ultrasound Useful in the Assessment for ILO? A Protocol for a Two-stage Exploratory Pilot Study
NCT05686941
Comparison of GlideScope Specific Stylet to Malleable Stylet for GlideScope Intubation
NCT00434720
A.I. Supported Laryngoscopy and Endotracheal Intubation: a Manikin Study
NCT06657417
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants
Participants will be required to attend a single consultation and screening appointment to discuss the investigation procedure, and this will occur at least a week before the Continuous Laryngoscopy during Exercise (CLE) test. Participants will then attend one appointment for the CLE test. There will be no follow up assessments using the headgear.
Continuous laryngoscopy during exercise test using the HALOS headgear
The participant will undergo the CLE test following standard clinical practice.
The order of events of the aspects of the investigation related to the headgear will be:
1. The headgear is prepared for use.
2. The headgear is fitted onto the participant's head.
3. The endoscope is inserted into the participant.
4. The endoscope is fitted onto the headgear.
5. The CLE test is carried out.
6. The endoscope is removed from the headgear.
7. The endoscope is removed from the participant.
8. The headgear is removed from the participant.
9. The headgear is cleaned and stored.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous laryngoscopy during exercise test using the HALOS headgear
The participant will undergo the CLE test following standard clinical practice.
The order of events of the aspects of the investigation related to the headgear will be:
1. The headgear is prepared for use.
2. The headgear is fitted onto the participant's head.
3. The endoscope is inserted into the participant.
4. The endoscope is fitted onto the headgear.
5. The CLE test is carried out.
6. The endoscope is removed from the headgear.
7. The endoscope is removed from the participant.
8. The headgear is removed from the participant.
9. The headgear is cleaned and stored.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male, female or non-binary, aged 18 years or above.
* Able (in the Investigators opinion) and willing to comply with all study requirements.
* Able to undergo a CLE test as judged by the clinician, and where a clinical need of the test for the delivery of healthcare has been identified.
Exclusion Criteria
* Devices, e.g. cochlear implants, that impede the use of the headgear.
* Head circumference is less than 50cm or greater than 63cm, reflecting the 3rd centile for females and 97th centile for males, respectively (Bushby, 1992).
* Skull base/facial surgery or fracture within the previous six weeks
* Major or life threatening epistaxis within the previous six weeks
* Trauma to nasal cavity secondary to surgery or injury within the previous six weeks
* Sino-nasal and anterior skull base tumours/surgery
* Nasopharyngeal stenosis
* Craniofacial anomalies
* Hereditary haemorrhagic telangiectasia
* Severe movement disorders and/or severe agitation
* Vasovagal history
* Bleeding risks
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Liverpool University Hospitals NHS Foundation Trust
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tristan Payne
Role: PRINCIPAL_INVESTIGATOR
Liverpool University Hospitals NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Liverpool University Hospitals Nhs Foundation Trust
Liverpool, Merseyside, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SP0707
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.